Humacyte, Inc.
HUMAWDrugs in Pipeline
1
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Human Acellular Vessel (HAV) | Phase 3 | Renal Failure | - | - |
Frequently asked questions
What is in Humacyte, Inc.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in Humacyte, Inc.'s (HUMAW) pipeline across Phase 3. Its lead program is Human Acellular Vessel (HAV) (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Humacyte, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Humacyte, Inc. (HUMAW) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track HUMAW biotech catalysts?→
Add HUMAW to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Humacyte, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.